Business information provider Visiongain predicts that global contract manufacturing revenues will double from 2011 to 2021. The company says revenues will reach $64.07bn in 2016 - with a CAGR of 8.7% between 2010 and 2016 - driven by manufacturing of finished dosage forms.
Pharma Times
Wednesday 24 August 2011
Contract manufacturing to double in next 10 years
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment